---
id: clinical-ai-evaluation-beyond-accuracy
date: May 2026
dateSortKey: 2026-05-01
category: Clinical AI
readingTime: 6 min read
title: What real-world clinical AI evaluation needs beyond benchmark accuracy
excerpt: Notes on evaluating deployed LLM/RAG systems through clinician feedback, evidence quality, workflow fit, and phase-over-phase improvements.
links:
  - Related paper
---

## Why benchmark accuracy is not enough

A clinical AI system can look strong on a benchmark and still fail to help a care team. Benchmarks usually test whether a model can produce a correct answer under controlled conditions. Real clinical workflows test something broader: whether the system retrieves the right evidence, explains uncertainty, fits into existing review processes, and helps users make decisions faster without creating new safety risks.

For clinical trial matching, this gap is especially visible. A patient may appear eligible based on one note, but the final decision may depend on longitudinal evidence across labs, medication history, prior procedures, outside records, imaging reports, and criterion-specific time windows. A single accuracy number cannot show whether the system found the right evidence or whether a clinical research coordinator could trust the output.

## Evidence quality should be evaluated directly

In an LLM/RAG workflow, the answer is only as useful as the evidence behind it. I would evaluate whether each evidence snippet is correct, sufficient, recent enough, and aligned with the eligibility criterion being assessed. A wrong answer with weak evidence is obviously problematic, but a correct answer with incomplete evidence can also be unsafe because it may hide uncertainty from the reviewer.

This means evaluation should include evidence-level feedback, not only final match labels. Useful questions include:

- Did the retrieved text actually support the model's decision?
- Was important contradictory evidence missing?
- Did the model distinguish between absence of evidence and evidence of absence?
- Did date-window filtering work for criteria that depend on recency?

## Human feedback is not just a label source

Clinical reviewers should not be treated only as ground-truth label providers. Their feedback can reveal where the system design itself needs to improve: ambiguous criteria, missing data sources, duplicated evidence, confusing rationales, or outputs that are technically correct but not useful for workflow triage.

For a deployed system, I would analyze feedback at multiple levels: patient-level match decisions, criterion-level pass/fail/unknown judgments, evidence-level sufficiency, and qualitative comments. This creates a more actionable evaluation loop than a single aggregate metric.

## The right question is workflow value

The most important evaluation question is not simply, "Was the model right?" It is: "Did the system help the clinical team screen patients more reliably, transparently, and efficiently?" That requires measuring performance, evidence quality, reviewer trust, turnaround time, cost, and the types of cases where the system remains uncertain.

My preferred framing is phase-over-phase learning. After each release, the team should ask what failure modes appeared, which were fixed, which remain unresolved, and how the user experience changed. This makes clinical AI evaluation closer to continuous system improvement than one-time model validation.
